153 related articles for article (PubMed ID: 36682673)
1. Visualizing How to Use Antipsychotics for Agitated Delirium in the Last Days of Life.
Imai K; Morita T; Mori M; Kiuchi D; Yokomichi N; Miwa S; Okamoto S; Yamauchi T; Naito AS; Matsuda Y; Maeda I; Sugano K; Ikenaga M; Inoue S; Satomi E
J Pain Symptom Manage; 2023 Jun; 65(6):479-489. PubMed ID: 36682673
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Pharmacological Treatments for Agitated Delirium in the Last Days of Life.
Kawashima N; Yokomichi N; Morita T; Yabuki R; Hisanaga T; Imai K; Hirose Y; Shimokawa M; Miwa S; Yamauchi T; Okamoto S; Satomi E
J Pain Symptom Manage; 2024 May; 67(5):441-452.e3. PubMed ID: 38355071
[TBL] [Abstract][Full Text] [Related]
3. Neuroleptic strategies for terminal agitation in patients with cancer and delirium at an acute palliative care unit: a single-centre, double-blind, parallel-group, randomised trial.
Hui D; De La Rosa A; Wilson A; Nguyen T; Wu J; Delgado-Guay M; Azhar A; Arthur J; Epner D; Haider A; De La Cruz M; Heung Y; Tanco K; Dalal S; Reddy A; Williams J; Amin S; Armstrong TS; Breitbart W; Bruera E
Lancet Oncol; 2020 Jul; 21(7):989-998. PubMed ID: 32479786
[TBL] [Abstract][Full Text] [Related]
4. Prehospital Agitation and Sedation Trial (PhAST): A Randomized Control Trial of Intramuscular Haloperidol versus Intramuscular Midazolam for the Sedation of the Agitated or Violent Patient in the Prehospital Environment.
Isenberg DL; Jacobs D
Prehosp Disaster Med; 2015 Oct; 30(5):491-5. PubMed ID: 26323511
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of antipsychotics for managing agitated delirium in patients with advanced cancer: a secondary analysis of a multicenter prospective observational study in Japan (Phase-R).
Kurisu K; Inada S; Maeda I; Nobata H; Ogawa A; Iwase S; Uchida M; Akechi T; Amano K; Nakajima N; Morita T; Sumitani M; Yoshiuchi K
Support Care Cancer; 2024 Feb; 32(3):147. PubMed ID: 38326487
[TBL] [Abstract][Full Text] [Related]
6. The minimal clinically important difference of the Richmond Agitation-Sedation Scale in patients with cancer with agitated delirium.
Hui D; Hess K; Dibaj SS; Arthur J; Dev R; Dalal S; Reddy S; Bruera E
Cancer; 2018 May; 124(10):2246-2252. PubMed ID: 29469951
[TBL] [Abstract][Full Text] [Related]
7. Effect of Lorazepam With Haloperidol vs Haloperidol Alone on Agitated Delirium in Patients With Advanced Cancer Receiving Palliative Care: A Randomized Clinical Trial.
Hui D; Frisbee-Hume S; Wilson A; Dibaj SS; Nguyen T; De La Cruz M; Walker P; Zhukovsky DS; Delgado-Guay M; Vidal M; Epner D; Reddy A; Tanco K; Williams J; Hall S; Liu D; Hess K; Amin S; Breitbart W; Bruera E
JAMA; 2017 Sep; 318(11):1047-1056. PubMed ID: 28975307
[TBL] [Abstract][Full Text] [Related]
8. High-dose neuroleptics and neuroleptic rotation for agitated delirium near the end of life.
Bascom PB; Bordley JL; Lawton AJ
Am J Hosp Palliat Care; 2014 Dec; 31(8):808-11. PubMed ID: 24081790
[TBL] [Abstract][Full Text] [Related]
9. Personalized sedation goal for agitated delirium in patients with cancer: Balancing comfort and communication.
Hui D; De La Rosa A; Urbauer DL; Nguyen T; Bruera E
Cancer; 2021 Dec; 127(24):4694-4701. PubMed ID: 34432293
[TBL] [Abstract][Full Text] [Related]
10. Are common delirium assessment tools appropriate for evaluating delirium at the end of life in cancer patients?
Uchida M; Morita T; Akechi T; Yokomichi N; Sakashita A; Hisanaga T; Matsui T; Ogawa A; Yoshiuchi K; Iwase S;
Psychooncology; 2020 Nov; 29(11):1842-1849. PubMed ID: 32735046
[TBL] [Abstract][Full Text] [Related]
11. Association among rescue neuroleptic use, agitation, and perceived comfort: secondary analysis of a randomized clinical trial on agitated delirium.
Tang M; Chen M; Bruera E; Hui D
Support Care Cancer; 2021 Dec; 29(12):7887-7894. PubMed ID: 34184130
[TBL] [Abstract][Full Text] [Related]
12. Propofol-Based Palliative Sedation to Treat Antipsychotic-Resistant Agitated Delirium.
Covarrubias-Gómez A; López Collada-Estrada M
J Pain Palliat Care Pharmacother; 2017; 31(3-4):190-194. PubMed ID: 28506099
[TBL] [Abstract][Full Text] [Related]
13. Drug therapy for delirium in terminally ill adults.
Finucane AM; Jones L; Leurent B; Sampson EL; Stone P; Tookman A; Candy B
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004770. PubMed ID: 31960954
[TBL] [Abstract][Full Text] [Related]
14. Delirium, agitation, and symptom distress within the final seven days of life among cancer patients receiving hospice care.
de la Cruz M; Noguera A; San Miguel-Arregui MT; Williams J; Chisholm G; Bruera E
Palliat Support Care; 2015 Apr; 13(2):211-6. PubMed ID: 24556057
[TBL] [Abstract][Full Text] [Related]
15. Comparison and agreement between the Richmond Agitation-Sedation Scale and the Riker Sedation-Agitation Scale in evaluating patients' eligibility for delirium assessment in the ICU.
Khan BA; Guzman O; Campbell NL; Walroth T; Tricker JL; Hui SL; Perkins A; Zawahiri M; Buckley JD; Farber MO; Ely EW; Boustani MA
Chest; 2012 Jul; 142(1):48-54. PubMed ID: 22539644
[TBL] [Abstract][Full Text] [Related]
16. 'Palliative sedation'? A retrospective cohort study on the use and labelling of continuously administered sedatives on a palliative care unit.
Schildmann E; Pörnbacher S; Kalies H; Bausewein C
Palliat Med; 2018 Jul; 32(7):1189-1197. PubMed ID: 29557260
[TBL] [Abstract][Full Text] [Related]
17. Pain, Agitation, and Delirium Guidelines: Interprofessional Perspectives to Translate the Evidence.
Jablonski J; Gray J; Miano T; Redline G; Teufel H; Collins T; Pascual-Lopez J; Sylvia M; Martin ND
Dimens Crit Care Nurs; 2017; 36(3):164-173. PubMed ID: 28375992
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous olanzapine for hyperactive or mixed delirium in patients with advanced cancer: a preliminary study.
Elsayem A; Bush SH; Munsell MF; Curry E; Calderon BB; Paraskevopoulos T; Fadul N; Bruera E
J Pain Symptom Manage; 2010 Nov; 40(5):774-82. PubMed ID: 20728301
[TBL] [Abstract][Full Text] [Related]
19. Neuroleptic malignant syndrome complicating antipsychotic treatment of delirium or agitation in medical and surgical patients: case reports and a review of the literature.
Seitz DP; Gill SS
Psychosomatics; 2009; 50(1):8-15. PubMed ID: 19213967
[TBL] [Abstract][Full Text] [Related]
20. Prescribing Practices of Valproic Acid for Agitation and Delirium in the Intensive Care Unit.
Quinn NJ; Hohlfelder B; Wanek MR; Duggal A; Torbic H
Ann Pharmacother; 2021 Mar; 55(3):311-317. PubMed ID: 32748626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
